financetom
Business
financetom
/
Business
/
Honeywell nears $2.2 billion deal for pump-and-compressor maker Sundyne, WSJ reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Honeywell nears $2.2 billion deal for pump-and-compressor maker Sundyne, WSJ reports
Mar 4, 2025 4:06 AM

(Reuters) -Honeywell International ( HON ) is closing in on a nearly $2.2 billion deal to buy pump-maker Sundyne from private-equity firm Warburg Pincus, the Wall Street Journal reported on Tuesday.

Honeywell ( HON ) and Sundyne did not immediately respond to Reuters' requests for comments.

The industrial giant Honeywell ( HON ) last month announced its plans to split into three independently listed companies, breaking up one of America's last standing conglomerates just months after activist investor Elliott Management took a $5 billion stake in Honeywell ( HON ).

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Ryan Specialty's Board Approves Leadership Succession Plan
Ryan Specialty's Board Approves Leadership Succession Plan
Jul 1, 2024
08:16 AM EDT, 07/01/2024 (MT Newswires) -- Ryan Specialty Group Holdings (RYAN) said Monday that its board of directors has unanimously approved a leadership succession plan to be implemented on Oct. 1. Under the plan, Chairman and Chief Executive Officer, Patrick G. Ryan, will transition to the role of executive chairman, and Chairman and CEO of Ryan Turner Specialty, Timothy...
Vera Therapeutics Appoints David Johnson as Chief Operating Officer
Vera Therapeutics Appoints David Johnson as Chief Operating Officer
Jul 1, 2024
08:24 AM EDT, 07/01/2024 (MT Newswires) -- Vera Therapeutics ( VERA ) said Monday it appointed David Johnson as Chief Operating Officer, effective immediately. Before joining Vera, Johnson served as the Chief Commercial Officer at Global Blood Therapeutics until it was acquired by Pfizer ( PFE ) in 2022, the company said. ...
Neurocrine Biosciences Says US FDA Accepts NDAs With Priority Review for Adrenal Gland Disease Drug
Neurocrine Biosciences Says US FDA Accepts NDAs With Priority Review for Adrenal Gland Disease Drug
Jul 1, 2024
08:22 AM EDT, 07/01/2024 (MT Newswires) -- Neurocrine Biosciences ( NBIX ) said Monday that the US Food and Drug Administration has accepted two New Drug Applications with Priority review designations for for crinecerfont, to treat children, adolescents, and adults with classic congenital adrenal hyperplasia. The company said the submitted applications for crinecerfont include a capsule formulation and an oral...
Fennec Pharmaceuticals Chief Operating Officer Adrian Haigh Steps Down
Fennec Pharmaceuticals Chief Operating Officer Adrian Haigh Steps Down
Jul 1, 2024
08:15 AM EDT, 07/01/2024 (MT Newswires) -- Fennec Pharmaceuticals ( FENC ) said Monday that Adrian Haigh stepped down as chief operating officer, effective June 30. The company is searching for a US-based COO, Fennec Chief Executive Rosty Raykov said. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved